Skip to main content

Table 1 Prevalence of SpA in Latin American countries

From: Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Country Study Setting/Population N Diagnosis Diagnostic criteria n Prevalence (%) 95% CI
Colombia Londoño et al., 2018 [6] 6 Colombian cities 6693 uSpA ESSG n/r 0.28 0.13–0.61
AS n/r n/r 0.11 0.03–0.36
Fernández-Ávila et al., 2018 (CA) [7] Colombia n/r AS n/r 84,356 0.18 n/r
PsA n/r 1670 0.004 n/r
Cuba Reyes-Llerena et al., 2009 [8] Havana 3155 AS n/r 6 0.1 0.07–0.4
Male 1238 AS n/r 4 0.3 n/r
Female 1917 AS n/r 2 0.1 n/r
Mexico Peláez-Ballestas et al., 2011 [9] 5 Mexican regions 19,213 AS mNYC n/r 0.1 0.1–0.2
Mexico City 4059 AS mNYC n/r 0.09 0.02–0.2
Nuevo León 4712 AS mNYC n/r 0.04 0.05–0.10
Yucatán 3195 AS mNYC n/r 0.04 0.05–0.10
Sinaloa 4879 AS mNYC n/r 0.2 0.1–0.40
Chihuahua 1647 AS mNYC n/r 0.6 0.2–1.1
Adjusted point prevalence, total 19,213 AS mNYC n/r 0.15 0.09–0.20
Male 7611 AS mNYC n/r 0.18 0.09–0.28
Female 11,602 AS mNYC n/r 0.11 0.05–0.17
Rodriguez-Amado et al., 2011 [10] Nuevo León 4713 PsA n/r 4 0.08 0.02–0.2
AS mNYC 2 0.04 0.05–0.1
Alvarez-Nemegyei et al., 2011 [11] Yucatán 3195 AS mNYC 1 0.02
PsA Surveying physician 1 0.02
Peláez-Ballestas et al., 2013 [12] Mexico City 4059 SpA ESSG 28 0.6 0.4–0.9
AS mNYC 4 0.09 0.02–0.2
Del Río Nájera et al., 2016 [13] Raramuri community 380 AS mNYC 3 0.8 0.0–1.8
Julián-Santiago et al., 2016 [14] Mixtec & Chontal communities 1061 AS mNYC 1 0.09 0.002–0.5
Mixtec 937 AS mNYC 1 0.1 0.002–0.5
Chontal 124 AS mNYC
Peláez-Ballestas et al., 2009 (CA) [15] Mexico City 9269 SpA ESSG 36 0.9 0.6–1.3
axSpA ASAS–1 39 0.9 0.7–1.3
axSpA ASAS–2 10 0.2 0.1–0.4
Venezuela Granados et al., 2016 [16] Warao, Kari’ña, and Chaima communities 1537 SpA mNYC 7 0.4 0.1–0.9
Warao 583 SpA mNYC
Kari’ña 262 SpA mNYC 2 0.7 0.09–2.7
Chaima 692 SpA mNYC 5 0.7 0.2–1.6
  1. References are articles unless indicated as conference abstracts (CA)
  2. AS ankylosing spondylitis, ASAS Assessment in Spondyloarthritis International Society, CA conference abstract, CI confidence interval, ESSG European Spondyloarthropathy Study Group, mNYC modified New York criteria, N number of patients in study, n number of patients with specified condition, n/r not reported, SpA spondyloarthritis, uSpA undifferentiated spondyloarthritis